home All News open_in_new Full Article

Esteve firma un acuerdo de licencia con Eton para un tratamiento de un factor de crecimiento

El laboratorio catalán refuerza su cartera de productos para enfermedades raras y añade su primer fármaco biológico, con la distribución de Increlex a nivel global, excepto en EEUU. Leer


today 6 d. ago attach_file Politics

attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Technology
attach_file Politics
attach_file Politics


ID: 3589728457
Add Watch Country

arrow_drop_down